Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors

Authors

  • Hilda Wong Division of Haematology/Oncology, Department of Medicine, The University of Hong Kong, Hong Kong
  • Thomas Yau Division of Haematology/Oncology, Department of Medicine, The University of Hong Kong, Hong Kong
  • Chan Wai Man Division of Haematology/Oncology, Department of Medicine, The University of Hong Kong, Hong Kong
  • Richard J. Epstein Division of Haematology/Oncology, Department of Medicine, The University of Hong Kong, Hong Kong

DOI:

https://doi.org/10.3109/02841860902980453

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2009-01-01

How to Cite

Wong, H., Yau, T., Wai Man, C., & Epstein, R. J. (2009). Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors. Acta Oncologica, 48(8), 1213–1215. https://doi.org/10.3109/02841860902980453

Issue

Vol. 48 No. 8 (2009): Acta Oncologica

Section

Articles